期刊文献+

儿童骨质疏松症及相关问题 被引量:3

Pediatric Osteoporosis and Related Problems
下载PDF
导出
摘要 骨质疏松症在成人已经是一个明确的临床问题,但在儿科却是一个全新的和不断变化的领域,面临一系列诸如发病机制、诊断标准及治疗药物的选择等临床问题和挑战。最近,对于儿童骨质疏松症的认识已有很大提高,不论是由于基因突变和酶缺陷所致的原发性骨质疏松还是继发于各种疾病、药物及生活方式的继发性骨质疏松症,都已进行了更加深入的研究。该文综述了骨质疏松症的常见问题,包括导致原发性骨质疏松症的候选突变基因及酶缺乏,继发性骨丢失的发病机制,以及可能的诊断、预防或治疗方法。旨在总结小儿骨质疏松症及相关骨问题,提高医师及患者对疾病的认识和重视程度,并提供最合适的方法来检测、治疗或防止此类问题的发生。 Osteoporosis is a well-established clinical problem in adults, while in pediatrics, it is a new and evolving area, with a series of clinical problems and challenges such as, pathogenesis, diagnosis and treatment medication. Recently, there has been an increased awareness of osteoporosis in children. Both the primary osteoporosis due to genetic mutations and enzyme deficiencies, and the secondary ostcoporosis due to various diseases, medications, and lifestyle issues have been studied deeply. Here is to make a review of the common problems of osteoporosis,including the genetic mutations and enzyme deficiencies that can lead to the primary osteoporosis ,the pathogenesis of secondary bone loss, as well as the possible ways of diagnosing, preventing,or treating with such conditions. This review is aiming at enhancing the doctor and patient's understanding of this disease, and providing reference on the most appropriate ways to detect, treat, and prevent such problems from happening.
作者 马继军 胡坚
出处 《医学综述》 2014年第15期2769-2771,共3页 Medical Recapitulate
关键词 骨质疏松 儿童 发病机制 Osteoporosis Children Pathogencsis
  • 相关文献

参考文献28

  • 1Bianchi ML, Bairn S, Bishop N J, et al. Official positions of the International Society for Clinical Densitometry on DXA evaluation in children and adolescents[J]. Pediatr Nephrol,2010,25 ( 1 ) :37- 47.
  • 2Marini JC, Forlino A, Cabral WA,et al. Consortium for osteogenesis impeffecta mutations in the helical domain of type I eollagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans [ J ]. Human Mutat, 2007,28 ( 3 ) : 209-221.
  • 3Carpenter TO. The expanding family of hypophosphatemic syn- dromes [ J ]. J Bone Miner Metab ,2012,30 ( 1 ) : 1-9.
  • 4Juarez Jiminez HG, Mier Cisneros R, Peralta Cruz S. Mid-third fem- oral shaft fracture in a patient with hypophosphatemie rickets with a locking centmmedullary nail [ J ]. Aeta Ortop Mex, 2009,23 ( 4 ) : 193-196.
  • 5Jonas J, Bums J, Abel EW, et al. Impaired mechanical strength of bone in experimental copper deficiency [ J]. Ann Nutr Metab, 1993,37 (5) :245-252.
  • 6Whyte MP, Reinus WR, Podgomik MN, et al. Familial expansile osteolysis (excessive RANK effeet ) in a 5-generation American kindred [ J ]. Medicine ( Baltimore), 2002,81 ( 2 ) : 101-121.
  • 7Klein GL, Bi LX, Sherrard D J, et al. Evidence supporting a role of glucoeortieoids in the short-term bone loss in burned children [ J ]. Osteoporos Int 2004,15 (6) :468-474.
  • 8Murphey ED,Chattopadhyay N, Bai M, et al. Up-regulation of the parathyroid calcium-sensing receptor after burn injury in sheep: a potential contributory factor to post-bum hypocalcemia [ J ]. Crit Care Med,2000,28(12) :3885-3890.
  • 9Thayu M, Leonard MB, Hyams JS ,et al. Improvement in biomarkers of bone formation during infliximab therapy in pediatric Crohn's disease :results of the REACH study [ J ]. Clin Gastroenterol Hepatol, 2008,6 ( 12 ) : 1378-1384.
  • 10Lim SH, Benseler SM, Tyrrell PN, et al. Low bone mineral density is present in newly-diagnosed paediatrie systemic lupus erythemato- sus patients[ J]. Ann Rheum Dis ,2011,70 ( 11 ) : 1991-1994.

同被引文献46

  • 1邹世恩,张绍芬.雌激素对成骨细胞和破骨细胞凋亡的调节机制[J].现代妇产科进展,2006,15(7):547-548. 被引量:18
  • 2刘学军.骨质疏松症[J].中国矫形外科杂志,2006,14(21):1668-1670. 被引量:26
  • 3贾少杰,贾晓静.雌激素抗骨质疏松的OPG/RANKL和ApoE作用机制的实验研究[J].中国老年学杂志,2007,27(23):2274-2276. 被引量:6
  • 4Honig S, Rajapakse CS, Chang G. Current treatment approaches to osteoporosis-2013 [J~. Bull Hosp Jt Dis, 2013, 71(3):184 188.
  • 5Mundy G, Garrett R, Harris S, et al. Stimulation of bone formation in vitro and in rodents by statinsEJ~. Science, 1999, 286(5446) : 1946-1949.
  • 6Thabit A, Alhifany A, Alsheikh R, et al. Effect of simvastatin and atorvastatin on serum vitamin D and bone mineral density in hypercholesterolemic pa- tients: a cross sectional study E Jl. J Osteoporos, 2014:1-9.
  • 7Gotoh M, Mizuno K, Ono Y, et al. Fiuvastatin in creases bone mineral density in postmenopausalwomen[J]. Fukushima J Med Sci, 2011, 57(1) : 19- 27.
  • 8Abel T, Feh4r J. [Role of rosuvastatin in current lipid-lowering therapy~ ]-J~. Orv Hetil, 2010, 151 (35) .- 1424-1428.
  • 9Tsartsalis AN, Dokos C, Kaiafa GD, et al. Statins, bone formation and osteoporosis, hope or hype? ~J~. Hormones (Athens), 2012, 1l(2) ~ 126-139.
  • 10Nakashima Y, Haneji T. Stimulation of osteoclast formation by RANKL requires interferon regulatory factor-4 and is inhibited by simvastatin in a mouse model of bone loss[J]. PloS One, 2013, 8(9): e72033.

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部